Felix Lansing

Title: Innovations in Genetic Alteration by Felix Lansing

Introduction

Felix Lansing is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of genetic engineering, particularly through his innovative patent that focuses on genome editing. His work aims to provide precise methods for altering DNA sequences, which can have profound implications in medicine.

Latest Patents

Felix Lansing holds a patent titled "Methods and means for genetic alteration of genomes utilizing designer DNA recombining enzymes." This invention offers methods for specifically altering the DNA sequence in a genome, particularly for genome editing by deleting or replacing a sequence of interest. The invention utilizes two non-identical sequences that naturally occur in a genome as target sites for generating DNA-recombining enzymes. This approach is particularly useful in medicine for repairing mutations in genomes or deleting predefined genetic material from cells or tissues to cure diseases. A significant advantage of this invention is its ability to allow precise site-directed alterations of DNA without engaging host DNA repair pathways, thereby avoiding random insertions and deletions.

Career Highlights

Felix Lansing is affiliated with the Technische Universität Dresden, where he continues to advance his research in genetic engineering. His work has garnered attention for its potential applications in treating genetic disorders and enhancing our understanding of genome functionality.

Collaborations

Felix has collaborated with notable colleagues such as Frank Buchholz and Martin Schneider, contributing to a rich environment of innovation and research at his institution.

Conclusion

Felix Lansing's contributions to genetic alteration through his innovative patent highlight the potential for advancements in medical science. His work exemplifies the intersection of technology and biology, paving the way for future breakthroughs in genome editing.